Centrica Shares Dip Following Downgrade: Cites Lack of Near-Term Catalysts

Centrica shares (LON: CNA) are trading 1.56% lower at 196.05p this morning after Jefferies downgraded the energy supplier from Buy to Hold, marking the latest in a series of analyst revisions that have tempered market enthusiasm for the British Gas owner.

The downgrade comes despite Jefferies raising its price target to 210p from 200p, with analyst Ahmed Farman pointing to an absence of near-term catalysts and the prospect of negative earnings revisions as key concerns weighing on the stock.

The Jefferies reassessment reflects growing caution among analysts following Centrica’s strategic pivot away from shareholder returns toward capital-intensive infrastructure investments. The company completed its £2 billion share buyback programme in February and immediately announced a pause on further repurchases to fund major projects, including a 15% stake in the Sizewell C nuclear power station and the acquisition of the Grain liquefied natural gas terminal.

While CEO Chris O’Shea framed the decision as creating lasting shareholder value whilst ensuring reliable and affordable energy supply, markets have responded with measured scepticism about the near-term earnings trajectory.

Financial performance has deteriorated markedly from the elevated levels seen during the energy crisis. Underlying earnings dropped to £814 million in 2025 from £1.55 billion the previous year, whilst adjusted operating profit in the first half of 2025 halved to £500 million from over £1 billion in the comparable period.

The company attributed the decline to mild weather conditions, falling wholesale energy prices, and weaker returns from gas storage operations, factors that have fundamentally altered the earnings landscape from the windfall conditions of recent years.

What Next For Centrica?

Adding to investor unease, CEO Chris O’Shea’s £3.6 million compensation package for 2025, comprising a £1.4 million annual bonus and £2.2 million in long-term share awards, has drawn scrutiny given the sharp profit decline. Nearly 40% of shareholders voted against the board’s remuneration plans at the previous annual general meeting, highlighting governance concerns that continue to simmer beneath the surface.

The Sizewell C investment represents a significant strategic bet, with Centrica projecting an internal rate of return between 10% and 12% alongside a 20-year offtake agreement.

Management believes this will enhance earnings visibility and position the company within the UK’s nuclear renaissance. However, the capital commitment comes at a time when immediate cash generation has weakened considerably, creating a tension between long-term strategic positioning and near-term shareholder returns.

Markets now face a period of recalibration as Centrica transitions from a high-cash-generation model to a capital-deployment phase. The Centrica share price sits below the consensus analyst target range, suggesting modest upside potential, yet the lack of buyback support and earnings headwinds identified by Jefferies may limit momentum until clearer operational catalysts emerge from the company’s infrastructure investments.